The 36-month beta value for PRPH is also noteworthy at -0.41. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for PRPH is 25.70M, and at present, short sellers hold a 0.33% of that float. The average trading volume of PRPH on February 13, 2025 was 609.90K shares.
PRPH) stock’s latest price update
The stock price of ProPhase Labs Inc (NASDAQ: PRPH) has jumped by 31.34 compared to previous close of 0.28. Despite this, the company has seen a gain of 41.75% in its stock price over the last five trading days. seekingalpha.com reported 2024-11-15 that ProPhase Labs, Inc. (NASDAQ:PRPH ) Q3 2024 Results Conference Call November 13, 2024 11:00 AM ET Company Participants Noella Alexander-Young – Renmark Financial Communications Ted Karkus – Chief Executive Officer Noella Alexander-Young Welcome to today’s presentation. My name is Noella Alexander-Young, Virtual Event Moderator here at Renmark Financial Communications.
PRPH’s Market Performance
PRPH’s stock has risen by 41.75% in the past week, with a monthly drop of -39.16% and a quarterly drop of -50.15%. The volatility ratio for the week is 12.59% while the volatility levels for the last 30 days are 18.29% for ProPhase Labs Inc The simple moving average for the last 20 days is -6.03% for PRPH’s stock, with a simple moving average of -85.07% for the last 200 days.
Analysts’ Opinion of PRPH
Many brokerage firms have already submitted their reports for PRPH stocks, with H.C. Wainwright repeating the rating for PRPH by listing it as a “Buy.” The predicted price for PRPH in the upcoming period, according to H.C. Wainwright is $12 based on the research report published on December 20, 2021 of the previous year 2021.
Dawson James gave a rating of “Buy” to PRPH, setting the target price at $25 in the report published on January 20th of the previous year.
PRPH Trading at -35.27% from the 50-Day Moving Average
After a stumble in the market that brought PRPH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.07% of loss for the given period.
Volatility was left at 18.29%, however, over the last 30 days, the volatility rate increased by 12.59%, as shares sank -41.69% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -54.67% lower at present.
During the last 5 trading sessions, PRPH rose by +34.63%, which changed the moving average for the period of 200-days by -92.57% in comparison to the 20-day moving average, which settled at $0.3911. In addition, ProPhase Labs Inc saw -51.34% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for PRPH
Current profitability levels for the company are sitting at:
- -2.78 for the present operating margin
- -0.32 for the gross margin
The net margin for ProPhase Labs Inc stands at -2.18. The total capital return value is set at -0.56. Equity return is now at value -58.71, with -30.25 for asset returns.
Based on ProPhase Labs Inc (PRPH), the company’s capital structure generated 0.44 points at debt to capital in total, while cash flow to debt ratio is standing at -0.48. The debt to equity ratio resting at 0.78. The interest coverage ratio of the stock is -12.6.
Currently, EBITDA for the company is -14.83 million with net debt to EBITDA at -1.07. When we switch over and look at the enterprise to sales, we see a ratio of 3.15. The receivables turnover for the company is 0.4for trailing twelve months and the total asset turnover is 0.14. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.47.
Conclusion
In summary, ProPhase Labs Inc (PRPH) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
